9 studies found for:    Open Studies | "Cellulitis"
Show Display Options
Rank Status Study
1 Recruiting Use of Corticosteroids in Children With Cellulitis
Condition: Cellulitis
Interventions: Drug: Dexamethasone;   Drug: Normal Saline
2 Recruiting Predictors of Oral Antibiotic Treatment Failure in Emergency Department Patients With Cellulitis
Condition: Cellulitis
Intervention:
3 Recruiting Duration of ANtibiotic Therapy for CEllulitis
Conditions: Cellulitis;   Erysipelas
Interventions: Drug: Flucloxacillin;   Drug: Placebo (for flucloxacillin)
4 Recruiting Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital
Condition: Cellulitis
Interventions: Other: Home;   Other: Ward;   Drug: ceftriaxone;   Drug: flucloxacillin
5 Not yet recruiting Fast Magnetic Resonance Imaging as Compared to Computed Tomography Scan in Pediatric Orbital Cellulitis Imaging
Condition: Orbital Cellulitis
Interventions: Device: Computed Tomography Scan;   Device: Fast Magnetic Resonance Imaging
6 Not yet recruiting Penicillin for the Emergency Department Outpatient Treatment of CELLulitis
Conditions: Cellulitis;   Wound Infection;   Abscess
Interventions: Drug: Flucloxacillin;   Drug: Phenoxymethylpenicillin;   Drug: Placebo (for phenoxymethylpenicillin)
7 Not yet recruiting Microbiology of Severe Acute Tonsillitis, Peritonsillar Cellulitis, and Infectious Mononucleosis
Conditions: Acute Tonsillitis;   Peritonsillar Cellulitis;   Infectious Mononucleosis
Intervention: Other: Throat swabbing
8 Not yet recruiting Hospitalization at Home: The Acute Care Home Hospital Program for Adults
Conditions: Pneumonia;   Heart Failure;   Cellulitis;   Urinary Tract Infections
Interventions: Other: Home hospitalization;   Other: Inpatient Hospitalization
9 Not yet recruiting Sivextro in Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global Observational Study
Conditions: Abscess;   Cellulitis;   Erysipelas;   Wound Infection
Interventions: Drug: Tedizolid (Sivextro, BAY 11-70438);   Drug: Linezolid

Study has passed its completion date and status has not been verified in more than two years.